Market closed · Next open: Wednesday 9:30 AM ET
Last update: Oct 27, 2026, 6:19 PM ET
Universal Health Services, Inc.
$177.32▼ 4.52% today
Market Closed

Why Universal Health Services, Inc. (UHS) stock moved

Updated Oct 28, 2026

Universal Health Services, Inc. (UHS) shares fell 4.5% to $177.32 as of October 28, 2026, a moderate decline from the prior close of $185.71. BestStocks flagged the session as a major change for UHS. The move is tied to price move down. Below, we break down what changed for UHS, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

UHS fell 4.5% to $177.32

UHS fell 4.5% in its latest session, moving from $185.71 to $177.32.

Material / EarningsMedium confidence
Rel. volume
1.6×
Above Avg
Vs peers
—
No comparable peers
Market cap
$9.2B
New York Stock Exchange
Analyst target
$193
+8.8% vs price
Price chart
Sep 28 – Oct 28
ENNFENNENN$174$181$189Sep 28Oct 6Oct 13Oct 21Oct 28
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Universal Health Services, Inc. investors

For Universal Health Services, Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Positive price momentum. Weighing against that: Material negative event; Negative session, down 4.5%. Wall Street's consensus price target sits at $193.00, implying +8.8% upside from $177.32. BestStocks rates the overall signal quality medium (61/100). With earnings roughly 119 days out, the next report is the most likely near-term test of the move.

UHS price reaction

UHS last traded at $177.32, down $8.39 (-4.52%) from the previous close of $185.71. The session traded on 1.6× average volume (above avg), so the move carried above-average conviction. Over the past month the stock has ranged between $174.26 and $188.13, and it currently sits about 22% of the way up that band.

Bullish and bearish analyst opinions on Universal Health Services, Inc. (UHS)

The consensus analyst price target on Universal Health Services, Inc. (UHS) is $193.00, 8.8% above the recent $177.32. Over the past 90 days analysts logged 0 upgrades, 4 maintains, and 0 downgrades. Here is how the bullish and bearish cases on UHS line up.

The bullish case

  • Wall Street's consensus price target of $193.00 implies +8.8% upside from $177.32.
  • The Street's most bullish target is $290.00 (+63.5%).
  • Positive price momentum.

The bearish case

  • The most bearish analyst target is $166.00 (-6.4%).
  • Material negative event.
  • Negative session, down 4.5%.
  • Universal Health Services, Inc. (UHS) moved -5.59% from $152.77 to $144.23 on 2026-07-14.
Bull vs bear balanceBearish Shift
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Oct 28, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $193+8.8%
= 4 maintains
Leerink Partners maintained Outperform · 2026-09-18
SEC filings watch
8-K2026-10-27
Material event — review for impact
high
8-K2026-08-21
Material event — review for impact
high
8-K2026-08-17
Material event — review for impact
high
8-K2026-08-13
Material event — review for impact
high
Peer context
UHS-4.5%

Previous notable changes for UHS

News2026-10-27-4.5%
UHS reported $308 million net income for Q3 2026, up from prior-year comparison.
Filings2026-10-27-4.5%
Universal Health Services, Inc. (UHS) filed an 8-K on October 27, 2026. The audit found only the filing date itself; the specific content and reason for the filing were not detailed in available evidence.
Material / Earnings2026-10-22+2.9%
Universal Health Services, Inc. (UHS) moved +2.60% from $183.36 to $188.13 on 2026-10-22, reaching a new 30-day high. The move came ahead of the company's scheduled Q3 2026 earnings report on 2026-10-26, with consensus expectations of $5.22 EPS and $4.71B in revenue.
News2026-10-21-1.5%
UHS Q3 revenues expected to rise from higher patient admissions amid wage pressures and rising operating costs.

In-depth UHS event analyses

Permanent, dated analyses of UHS's most significant sessions.
Upcoming catalysts & outlook
Next earnings
2027-02-24 (est.)
in 119 days
Earnings Release
2027-02-24
High impact
Thesis shift
Bearish Shift
bearish signal
Risk level
Medium
from change events

Frequently asked questions about UHS

Why did Universal Health Services, Inc. (UHS) stock move?

UHS fell 4.5% to $177.32. No single company-specific catalyst was confirmed during the move window, and it looks technical.

How much did UHS stock fall?

UHS lost 4.52% ($8.39) versus the prior close of $185.71, last trading at $177.32 on 1.6× average volume.

When is Universal Health Services, Inc.'s next earnings date?

UHS's next earnings report is estimated for 2027-02-24 — about 119 days away.

What is the analyst price target for UHS?

The consensus analyst price target for UHS is $193.00, about 8.8% above the current $177.32. Over the past 90 days, analysts recorded 0 upgrades, 4 maintains, and 0 downgrades.

How BestStocks tracks UHS

This page is generated automatically by BestStocks' change-detection system after price move down was detected and verified against independent data sources. It draws on 20 tracked change events for UHS, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 28, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataCompany news feedsSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.